Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8⁺ T-cell immune responses

References

• ShaibYHDavilaJAMcGlynnKEl-SeragHBRising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?J Hepatol200440347247715123362
   PubMed Web of Science ®Google Scholar
• ShaibYEl-SeragHBThe epidemiology of cholangiocarcinomaSemin Liver Dis200424211512515192785
   PubMed Web of Science ®Google Scholar
• BridgewaterJGallePRKhanSAGuidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJ Hepatol20146061268128924681130
   PubMed Web of Science ®Google Scholar
• EndoIGonenMYoppACIntrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resectionAnn Surg20082481849618580211
   PubMed Web of Science ®Google Scholar
• TopalianSLDrakeCGPardollDMImmune checkpoint blockade: a common denominator approach to cancer therapyCancer Cell201527445046125858804
   PubMed Web of Science ®Google Scholar
• BrahmerJRTykodiSSChowLQSafety and activity of anti-PD-L1 antibody in patients with advanced cancerN Engl J Med2012366262455246522658128
   PubMed Web of Science ®Google Scholar
• BalarAVWeberJSPD-1 and PD-L1 antibodies in cancer: current status and future directionsCancer Immunol Immunother201766555156428213726
   PubMed Web of Science ®Google Scholar
• DongHStromeSESalomaoDRTumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionNat Med20028879380012091876
   PubMed Web of Science ®Google Scholar
• ChenLGibbonsDLGoswamiSMetastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppressionNat Commun20145524125348003
   PubMed Web of Science ®Google Scholar
• ZouWWolchokJDChenLPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinationsSci Transl Med20168328rv4
   PubMed Web of Science ®Google Scholar
• HarlinHMengYPetersonACChemokine expression in melanoma metastases associated with CD8+ T-cell recruitmentCancer Res20096973077308519293190
   PubMed Web of Science ®Google Scholar
• JiRRChasalowSDWangLAn immune-active tumor micro-environment favors clinical response to ipilimumabCancer Immunol Immunother20126171019103122146893
   PubMed Web of Science ®Google Scholar
• GoeppertBFrauenschuhLZucknickMPrognostic impact of tumour-infiltrating immune cells on biliary tract cancerBr J Cancer2013109102665267424136146
   PubMed Web of Science ®Google Scholar
• AtefiMAvramisELassenAEffects of MAPK and PI3K pathways on PD-L1 expression in melanomaClin Cancer Res201420133446345724812408
   PubMed Web of Science ®Google Scholar
• TaubeJMAndersRAYoungGDColocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escapeSci Transl Med20124127ra37
   PubMed Web of Science ®Google Scholar
• SprangerSSpaapenRMZhaYUp-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cellsSci Transl Med20135200ra116
   PubMed Web of Science ®Google Scholar
• AminMBGreeneFLEdgeSBThe Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingCA Cancer J Clin2017672939928094848
   PubMed Web of Science ®Google Scholar
• ZhuYGaoXMYangJC–C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinomaCancer Sci2018109371072329285854
   PubMed Web of Science ®Google Scholar
• SiaDLosicBMoeiniAMassive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaNat Commun20156608725608663
   PubMed Web of Science ®Google Scholar
• SabbatinoFVillaniVYearleyJHPD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinomaClin Cancer Res201622247047826373575
   PubMed Web of Science ®Google Scholar
• RosenbaumMWBledsoeJRMorales-OyarvideVHuynhTGMino-KenudsonMPD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytesMod Pathol20162991104111227198569
   PubMed Web of Science ®Google Scholar
• HamanishiJMandaiMIwasakiMProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerProc Natl Acad Sci U S A200710493360336517360651
   PubMed Web of Science ®Google Scholar
• PatelSPKurzrockRPD-L1 Expression as a predictive biomarker in cancer immunotherapyMol Cancer Ther201514484785625695955
   PubMed Web of Science ®Google Scholar
• ThompsonEDZahurakMMurphyAPatterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stromaGut201766579480126801886
   PubMed Web of Science ®Google Scholar
• KarimRJordanovaESPiersmaSJTumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinomaClin Cancer Res200915206341634719825956
   PubMed Web of Science ®Google Scholar
• XieQKZhaoYJPanTProgrammed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinomaOncoimmunology201657e118125227622038
   PubMed Web of Science ®Google Scholar
• WölfleSJStrebovskyJBartzHPD-L1 expression on tolerogenic APCs is controlled by STAT-3Eur J Immunol201141241342421268011
   PubMed Web of Science ®Google Scholar
• KinterALGodboutEJMcNallyJPThe common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligandsJ Immunol2008181106738674618981091
   PubMed Web of Science ®Google Scholar
• RosenbergSAIL-2: the first effective immunotherapy for human cancerJ Immunol2014192125451545824907378
   PubMed Web of Science ®Google Scholar
• SunHCTangZYWangLPostoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trialJ Cancer Res Clin Oncol2006132745846516557381
   PubMed Web of Science ®Google Scholar
• SahinUTüreciÖPersonalized vaccines for cancer immunotherapyScience201835963821355136029567706
   PubMed Web of Science ®Google Scholar
• ChenDSMellmanIElements of cancer immunity and the cancer-immune set pointNature2017541763732133028102259
   PubMed Web of Science ®Google Scholar